ストックスクリーナーアプリを入手
0.012
5.75%
0.00065
Cero Therapeutics Holdings Inc (CERO) 最新ニュース
BTAIQ Stock Price and Chart — OTC:BTAIQ - TradingView
SRx Health Solutions Secures Major CERo Financing Deal - TipRanks
SRX Global (SRXH) lines up $11.7M for CERo, backed by its cell therapy assets - Stock Titan
CERo Therapeutics Holdings Secures New Consolidated Financing Facility - TipRanks
CERo Therapeutics (CERO) folds $5.7M debt into 10% secured note due Oct 2026 - Stock Titan
CERo Therapeutics Secures Up to $11.67 Million SRX Financing, Consolidates $5.67 Million Debt - TradingView
BCAB Stock Price and Chart — OTC:BCAB - TradingView
SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers - Yahoo Finance
CERo Therapeutics Holdings, Inc. announced that it has received $6 million in funding from SRx Health Solutions Inc. - marketscreener.com
Price to earnings forward of CERo Therapeutics Holdings, Inc. – OTC:CEROW - TradingView
CERo Therapeutics (CERO) warns on going concern as losses mount and deficit widens - Stock Titan
CERo Therapeutics Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Cero Therapeutics (CERO) holder Isaiah Tibbs reports 4.63% ownership stake - Stock Titan
CERo Therapeutics Holdings, Inc. Revenue Breakdown – OTC:CERO - TradingView
CERo Therapeutics Holdings, Inc. Revenue Breakdown – OTC:CEROW - TradingView
CERo Therapeutics Expands Convertible Debt Financing Arrangement - TipRanks
CERO Therapeutics (OTCQB: CERO) details $2,606,500 discounted convertible note funding - Stock Titan
Cero Therapeutics Secures $2.09M 10% Convertible Note With SRX Global, Maturing May 2027 - TradingView
CERO Therapeutics (CERO) details $2,085,200 10% convertible note deal - Stock Titan
BNBX Stock Price and Chart — OTC:BNBX - TradingView
CERo Therapeutics Holdings, Inc. announced that it has received $2.0852 million in funding from SRx Health Solutions Inc. - marketscreener.com
[25-NSE] CERO THERAPEUTICS HOLDINGS, INC. SEC Filing - Stock Titan
Delisting of Securities from The Nasdaq Stock Market - The Manila Times
Nasdaq to delist multiple suspended stocks incl... - Pluang
Price to earnings forward of CERo Therapeutics Holdings, Inc. – OTC:CERO - TradingView
Price to sales forward of CERo Therapeutics Holdings, Inc. – OTC:CERO - TradingView
Enterprise value to EBITDA forward of CERo Therapeutics Holdings, Inc. – OTC:CERO - TradingView
CERo Therapeutics Amends Convertible Note, Expands Private Financing - TipRanks
CERO Therapeutics (OTCQB: CERO) registers 729.6M shares; files convertible note details - Stock Titan
CERO Therapeutics (CERO) inks $1.41M 10% convertible note with stock conversion - Stock Titan
CERo Therapeutics Holdings, Inc. Actuals & Estimates (OTC:CERO) - TradingView
ADTX Stock Price and Chart — OTC:ADTX - TradingView
CERo Therapeutics Holdings Inc (CERO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CERo Therapeutics Holdings, Inc. announced that it has received $1.4136 million in funding from SRx Health Solutions Inc. - marketscreener.com
CERo Therapeutics Holdings Inc (CEROW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CERo Therapeutics Holdings Inc (CERO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CERo Therapeutics Holdings Inc - TradingKey
CERo Therapeutics Holdings Inc (CERO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CERo Therapeutics Holdings Inc (CERO) Institutional Confidence - TradingKey
CERo Therapeutics Holdings Inc (CERO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CERo Therapeutics Holdings Inc (CERO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CERo Therapeutics Holdings Inc (CERO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CERo Therapeutics Holdings Inc (CERO) Valuation: PE, PB & Fair Value Analysis - TradingKey
CERo Therapeutics Holdings Inc (CEROW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CERo Therapeutics Holdings Inc (CEROW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CERo Therapeutics Holdings Inc (CEROW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CERo Therapeutics Holdings Inc (CEROW) Valuation: PE, PB & Fair Value Analysis - TradingKey
CERo Therapeutics Holdings Inc (CEROW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CERo Therapeutics Holdings Inc (CEROW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CERo Therapeutics Holdings Inc (CEROW) Institutional Confidence - TradingKey
CERo Therapeutics Holdings Announces Clinical Update From CERTAIN-T Phase 1 CER-1236 Trial - marketscreener.com
CERo Therapeutics Announces Clinical Update from CERTAIN-T - GlobeNewswire
CERo Therapeutics Raises Funding via Convertible Note Financing - TipRanks
CERO (OTCQB: CERO) registers 729.6M shares as conversion resale coverage - Stock Titan
CERo Therapeutics Secures $750,000 10% Convertible Note With SRX Health Solutions, Due 2027 - TradingView
CERO Therapeutics (CERO) issues $750K 10% convertible note with 4.99% cap - Stock Titan
CERo Therapeutics Holdings, Inc. announced that it has received $0.75 million in funding from SRx Health Solutions Inc. - marketscreener.com
CEROW | CERO THERAPEUTICS WTS 29 Insider Trading - Quiver Quantitative
Maxim Group Initiates Coverage of CERo Therapeutics Holdings (CERO) with Buy Recommendation - MSN
CERo Therapeutics (OTCQB: CERO) registers 729.6M common shares; 10-Q updates show cash, loss - Stock Titan
CERo Therapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
CERo Therapeutics (OTCQB: CERO) warns of going-concern risk - Stock Titan
0.14%
0.15%
大文字化:
|
ボリューム (24 時間):